Nuveen, LLC Cor Medix Inc. Transaction History
Nuveen, LLC
- $348 Billion
- Q2 2025
A detailed history of Nuveen, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Nuveen, LLC holds 1,468,721 shares of CRMD stock, worth $16.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,468,721
Previous 274,681
434.7%
Holding current value
$16.9 Million
Previous $1.69 Million
969.39%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
162Shares Held
26.4MCall Options Held
475KPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.9 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl2.44MShares$28.1 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.6MShares$18.4 Million0.0% of portfolio
-
State Street Corp Boston, MA1.54MShares$17.7 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $474M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...